Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1016/s0140-6736(09)60325-1 | A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods |
| https://doi.org/10.1016/s0140-6736(08)60415-8 | A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial |
| https://doi.org/10.1016/s0140-6736(14)61455-0 | A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial |
| https://doi.org/10.1016/j.jacc.2011.05.050 | Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis |
| https://doi.org/10.1016/j.jacc.2015.11.060 | A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis |
| https://doi.org/10.1016/j.ejca.2015.08.027 | The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients |
| https://doi.org/10.1093/eurheartj/ehr466 | Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? |
| https://doi.org/10.1016/j.jcmg.2012.01.009 | Natural History of Coronary Atherosclerosis by Multislice Computed Tomography |
| https://doi.org/10.1016/j.atherosclerosis.2011.12.008 | Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: Can the scaffold cap the plaque? |
| https://doi.org/10.1161/circinterventions.108.831800.108.831800 | Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions |
| https://doi.org/10.1002/ccd.22541 | Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: Two‐year angiographic and three‐year clinical results from the SPIRIT II study |
| https://doi.org/10.1016/j.jcin.2013.05.034 | Effect of the Endothelial Shear Stress Patterns on Neointimal Proliferation Following Drug-Eluting Bioresorbable Vascular Scaffold Implantation |
| https://doi.org/10.1016/j.jcin.2014.06.016 | Incidence and Imaging Outcomes of Acute Scaffold Disruption and Late Structural Discontinuity After Implantation of the Absorb Everolimus-Eluting Fully Bioresorbable Vascular Scaffold |
| https://doi.org/10.1016/j.ahj.2012.08.010 | ABSORB II randomized controlled trial |
| https://doi.org/10.1016/j.jcin.2012.10.013 | Incidence and Short-Term Clinical Outcomes of Small Side Branch Occlusion After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold |
| https://doi.org/10.1016/j.jcin.2009.10.002 | 3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions |
| https://doi.org/10.1523/jneurosci.5721-09.2010 | Generation and Therapeutic Efficacy of Highly Oligomer-Specific β-Amyloid Antibodies |
| https://doi.org/10.1016/j.jcin.2010.07.016 | A Comparison of the Conformability of Everolimus-Eluting Bioresorbable Vascular Scaffolds to Metal Platform Coronary Stents |
| https://doi.org/10.1016/j.jacc.2016.06.022 | Transcatheter Edge-to-Edge Treatment of Functional Tricuspid Regurgitation in an Ex Vivo Pulsatile Heart Model |
| https://doi.org/10.1136/heartjnl-2012-302598 | Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial |
| https://doi.org/10.1016/j.jcin.2011.03.020 | Serial Analysis of the Malapposed and Uncovered Struts of the New Generation of Everolimus-Eluting Bioresorbable Scaffold With Optical Coherence Tomography |
| https://doi.org/10.1002/ccd.22428 | Five‐year long‐term clinical follow‐up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT FIRST trial |
| https://doi.org/10.1016/j.jcin.2011.08.016 | Head-to-Head Comparison of the Neointimal Response Between Metallic and Bioresorbable Everolimus-Eluting Scaffolds Using Optical Coherence Tomography |
| https://doi.org/10.1016/j.ahj.2012.02.006 | The SPIRIT V Diabetic Study: A randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions |
| https://doi.org/10.1093/eurheartj/ehq458 | A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds |
| https://doi.org/10.1016/j.jcin.2015.07.026 | Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II) |
| https://doi.org/10.1093/ehjci/jew035 | Prediction of atherosclerotic disease progression using LDL transport modelling: a serial computed tomographic coronary angiographic study |
| https://doi.org/10.1016/j.jcin.2014.01.155 | 1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds |
| https://doi.org/10.1016/j.crfs.2025.101055 | Stability of nutrients in complex liquid and powder food matrices: learnings from shelf-life studies in foods for special medical purposes |
| https://doi.org/10.1097/rli.0b013e31816a88a9 | Quantification of Coronary Plaque by 64-slice Computed Tomography: A Comparison with Quantitative Intracoronary Ultrasound |
| https://doi.org/10.2307/2555302 | Birbrower Montalbano, Condon and Frank v. Superior Court |
| https://doi.org/10.1016/j.jcin.2010.11.006 | The SPIRIT V Study |
| https://doi.org/10.1016/j.jcin.2011.04.009 | Angiographic Geometric Changes of the Lumen Arterial Wall After Bioresorbable Vascular Scaffolds and Metallic Platform Stents at 1-Year Follow-Up |
| https://doi.org/10.1016/j.jcin.2010.07.017 | Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents |
| https://doi.org/10.1016/j.jacc.2011.02.052 | 6-Month Clinical Outcomes Following Implantation of the Bioresorbable Everolimus-Eluting Vascular Scaffold in Vessels Smaller or Larger Than 2.5 mm |
| https://doi.org/10.1007/s10554-014-0374-3 | Fusion of optical coherence tomographic and angiographic data for more accurate evaluation of the endothelial shear stress patterns and neointimal distribution after bioresorbable scaffold implantation: comparison with intravascular ultrasound-derived reconstructions |
| https://doi.org/10.1002/ccd.22452 | An everolimus‐eluting stent versus a paclitaxel‐eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials |
| https://doi.org/10.1016/j.jcin.2015.06.001 | Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent |
| https://doi.org/10.1016/j.jcin.2010.02.004 | Monitoring In Vivo Absorption of a Drug-Eluting Bioabsorbable Stent With Intravascular Ultrasound-Derived Parameters |
| https://doi.org/10.1016/j.jcin.2012.02.017 | Vascular Response of the Segments Adjacent to the Proximal and Distal Edges of the ABSORB Everolimus-Eluting Bioresorbable Vascular Scaffold: 6-Month and 1-Year Follow-Up Assessment |
| https://doi.org/10.1093/eurheartj/ehp599 | Randomized comparison of everolimus- and paclitaxel-eluting stents: pooled analysis of the 2-year clinical follow-up from the SPIRIT II and III trials |
| https://doi.org/10.1007/s10072-013-1612-5 | Intestinal levodopa infusion: the Belgian experience |
| https://doi.org/10.1016/j.jbiomech.2016.11.013 | In vitro and in silico approaches to quantify the effects of the Mitraclip ® system on mitral valve function |
| https://doi.org/10.1017/s0266462320000756 | On the integration of early health technology assessment in the innovation process: reflections from five stakeholders |
| https://doi.org/10.2165/00044011-199816020-00009 | A Phase I Determination of Azithromycin in Plasma during a 6-Week Period in Normal Volunteers after a Standard Dose of 500mg Once Daily for 3 Days |
| https://doi.org/10.1002/ccd.22770 | Four‐year clinical follow‐up of the XIENCE V everolimus‐eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT II trial |
| https://doi.org/10.1007/s10554-010-9769-y | Morphological and functional evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS, echogenicity and vasomotion testing at two year follow-up: a patient level insight into the ABSORB A clinical trial |
| https://doi.org/10.1111/ner.13019 | Anatomic Lead Placement Without Paresthesia Mapping Provides Effective and Predictable Therapy During the Trial Evaluation Period: Results From the Prospective, Multicenter, Randomized, DELIVERY Study |
| https://doi.org/10.1016/j.jcin.2014.06.025 | Scaffold and Edge Vascular Response Following Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffold |
| https://doi.org/10.1007/s10554-010-9724-y | Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold |
| https://doi.org/10.1016/j.jcin.2016.12.020 | Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation |
| https://doi.org/10.1097/brs.0000000000004283 | Passive Recharge Burst Spinal Cord Stimulation Provides Sustainable Improvements in Pain and Psychosocial Function: 2-year Results From the TRIUMPH Study |
| https://doi.org/10.1093/jaoacint/qsac005 | The Challenge of Measuring Sweet Taste in Food Ingredients and Products for Regulatory Compliance: A Scientific Opinion |
| https://doi.org/10.1002/ccd.27715 | Three‐year clinical outcomes of patients treated with everolimus‐eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial |
| https://doi.org/10.1093/europace/euad068 | New insertable cardiac monitors show high diagnostic yield and good safety profile in real-world clinical practice: results from the international prospective observational SMART Registry |
| https://doi.org/10.1002/ehf2.14496 | Real-Time Pulmonary Artery Pressure Monitoring in Heart Failure Patients: An Updated Cost-Effectiveness Analysis |
| https://doi.org/10.1007/978-981-10-4068-9_34 | Medical Technologies: Involving Patients in Development and Assessment |
| https://doi.org/10.1002/ccd.22332 | IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus‐eluting device during the bioabsorption process |
| https://doi.org/10.1161/circinterventions.108.831800 | Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: The SPIRIT II Trial |
| https://doi.org/10.1016/j.jcin.2011.08.014 | Serial In Vivo Intravascular Ultrasound-Based Echogenicity Changes of Everolimus-Eluting Bioresorbable Vascular Scaffold During the First 12 Months After Implantation |
| https://doi.org/10.1093/ehjci/jex022 | Long-term serial non-invasive multislice computed tomography angiography with functional evaluation after coronary implantation of a bioresorbable everolimus-eluting scaffold: the ABSORB cohort B MSCT substudy |
| https://doi.org/10.1016/j.ihj.2014.03.007 | Three-year data from the XIENCE V® INDIA study: Safety and efficacy of XIENCE V® in 1000 real world Indian patients |
| https://doi.org/10.1093/eurheartj/ehv275 | Barriers to cardiovascular device innovation in Europe |
| https://doi.org/10.1177/1759720x211070205 | An oleuropein-based dietary supplement may improve joint functional capacity in older people with high knee joint pain: findings from a multicentre-RCT and post hoc analysis |
| https://doi.org/10.1016/j.ahj.2008.07.005 | Systemic exposure of everolimus after stent implantation: A pharmacokinetic study |
| https://doi.org/10.1007/s40121-016-0109-y | The Burden of Severe Respiratory Syncytial Virus Disease Among Children Younger than 1 Year in Central and Eastern Europe |
| https://doi.org/10.1002/ccd.24775 | Two‐year outcomes after deployment of XIENCE V everolimus‐eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: A report from the SPIRIT V single arm study |
| https://doi.org/10.1007/s40744-016-0051-1 | High Prevalence of Undiagnosed Axial Spondyloarthritis in Patients with Chronic Low Back Pain Consulting Non-Rheumatologist Specialists in Belgium: SUSPECT Study |
| https://doi.org/10.1007/s10439-017-1885-6 | Modelling of Lesions Associated with Functional Mitral Regurgitation in an Ex Vivo Platform |
| https://doi.org/10.1016/j.rec.2015.07.027 | Impact of the Everolimus-eluting Bioresorbable Scaffold in Coronary Atherosclerosis |
| https://doi.org/10.1007/s10554-011-9981-4 | Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold |
| https://doi.org/10.1016/j.iccl.2017.12.007 | History of Percutaneous Left Atrial Appendage Occlusion with AMPLATZER Devices |
| https://doi.org/10.3111/13696998.2012.691927 | Economic and health-related quality-of-life (HRQoL) comparison of lopinavir/ritonavir (LPV/r) and atazanavir plus ritonavir (ATV+RTV) based regimens for antiretroviral therapy (ART)-naïve and -experienced United Kingdom patients in 2011 |
| https://doi.org/10.1016/j.culher.2018.05.010 | Scenario configurations for the EU as a cultural heritage protection actor in armed conflicts |
| https://doi.org/10.3390/jpm12091512 | The Interplay of PR Interval and AV Pacing Delays Used for Cardiac Resynchronization Therapy in Heart Failure Patients: Association with Clinical Response in a Retrospective Analysis of a Large Observational Study |
| https://doi.org/10.1016/j.jval.2024.10.092 | CO15 Real-World Treatment Usage of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients in Belgium: Results of the AREVEDECY Study |
| https://doi.org/10.1093/clinchem/45.3.432 | Evaluation of the New AxSYM Cyclosporine Assay: Comparison with TDx Monoclonal Whole Blood and Emit Cyclosporine Assays |
| https://doi.org/10.1016/j.transproceed.2005.05.034 | Evaluation of a New Immunoassay to Measure Sirolimus Blood Concentrations Compared to a Tandem Mass-Spectrometric Chromatographic Analysis |
| https://doi.org/10.1109/ias.1991.178178 | Application of field oriented control in crane drives |
| https://doi.org/10.1016/j.jacc.2015.08.055 | TCT-11 Five-year Follow up of the First in Man use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis; A Serial Multi-Imaging Modality Study |
| https://doi.org/10.1007/s40258-020-00610-8 | Impact of Guidelines on the Diffusion of Medical Technology: A Case Study of Cardiac Resynchronization Therapy in the UK |
| https://doi.org/10.7448/ias.15.6.18385 | Cost‐effectiveness of atazanavir+ritonavir (ATV+RTV) vs. lopinavir/ritonavir (LPV/r) in women of childbearing age in the United Kingdom |
| https://doi.org/10.7448/ias.15.6.18372 | Cost of switching darunavir+ritonavir (DRV+RTV) to lopinavir/ritonavir (LPV/r) in HIV‐1‐infected treatment‐naïve women of child‐bearing age (WOCBA) |
| https://doi.org/10.1016/j.jacc.2015.08.058 | TCT-14 ABSORB FIRST: 1-year clinical outcomes from a prospective, multi-center, global, real-world registry |
| https://doi.org/10.2459/jcm.0000000000001236 | Determinants of worse prognosis in patients with cardiac resynchronization therapy defibrillators. Are ventricular arrhythmias an adjunctive risk factor? |
| https://doi.org/10.1016/j.jnnfm.2022.104830 | On the wall boundary condition for the velocity in concentrated suspensions |
| https://doi.org/10.1007/s12325-023-02427-y | Letter to the Editor Regarding Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently-Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands |
| https://doi.org/10.1093/ejcts/ezx205 | MitraClip removal: surgical techniques to preserve native mitral valve leaflets |
| Post-Confirmation Jurisdiction in the Bankruptcy Courts: Does it Ever End? | |
| https://doi.org/10.1016/j.amjcard.2012.01.443 | AS-214 A Clinical Evaluation of the XIENCE V Everolimus Eluting Stent in the Treatment of Women with Complex de novo Coronary Artery Lesions: Analysis of Chinese Subset from the SPIRIT Women Study |
| https://doi.org/10.1038/382490b0 | Is the Pope the Pope? |
| https://doi.org/10.1016/j.jval.2012.08.973 | PCV30 Assessment of the Hospital Costs of Mitral Regurgitation (MR) Patients, a French National Hospital Database Analysis |
| https://doi.org/10.1016/j.jval.2013.03.338 | Cost Minimization Comparison Of Darunavir + Ritonavir (DRV+RTV) To Lopinavir/Ritonavir (LPV/R) In HIV-1 Infected Treatment-Naïve Women Of Child Bearing Age (WOCBA) |
| https://doi.org/10.1017/s0266462314000312 | TRANSCATHETER AORTIC VALVE IMPLANTATION AND ADAPTIVE / PROGRESSIVE COVERAGE |
| https://doi.org/10.1016/j.jval.2012.08.1132 | PIN65 Cost-Effectiveness of First-Line Antiretroviral Regimens for Human Immunodeficiency Virus (HIV) in Colombia: An Analysis of Lopinavir/Ritonavir (LPV/R) and Darunavir Plus Ritonavir (DRV+RTV) in Treatment-Naïve Patients |
| https://doi.org/10.1136/archdischild-2012-302724.0846 | 846 Respiratory Syncytial Virus as Cause of Lower Respiratory Tract Infection in Young Children in Central and Eastern Europe |
| https://doi.org/10.1016/s2214-1235(15)30060-0 | Evaluation of the XIENCE™ V Everolimus-Eluting Coronary Stent System in the Female Latin American Population of the SPIRIT Women Single-Arm Study: One-year Clinical Follow-up Data |
| https://doi.org/10.1016/j.atherosclerosis.2016.07.162 | Reproducibility of endothelial shear stress and low density lipoprotein transport modeling in computed tomography angiographic imaging data |
| https://doi.org/10.1093/ecco-jcc/jjx002.305 | P180 Investing in workability of patients with IBD: results of a pilot project Activ84worK (Activate for worK) |
| https://doi.org/10.1093/eurheartj/ehx502.p1370 | P1370Ex-vivo pathological models of mitral and tricuspid regurgitation for realistic clinical training and new treatment approaches evaluation |